Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

Pancreatic Adenocarcinoma, Version 1.2019.

Author information

1
1UCSF Helen Diller Family Comprehensive Cancer Center.
2
2Moffitt Cancer Center.
3
3Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
4
4Duke Cancer Institute.
5
5Huntsman Cancer Institute at the University of Utah.
6
6The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
7
7Roswell Park Comprehensive Cancer Center.
8
8Dana-Farber/Brigham and Women's Cancer Center.
9
9University of Michigan Rogel Cancer Center.
10
10Mayo Clinic Cancer Center.
11
11St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
12
12Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
13
13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
14
14Vanderbilt-Ingram Cancer Center.
15
15Yale Cancer Center/Smilow Cancer Hospital.
16
16City of Hope National Medical Center.
17
17The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
18
18Fox Chase Cancer Center.
19
19Massachusetts General Hospital Cancer Center.
20
20Stanford Cancer Institute.
21
21Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
22
22University of Wisconsin Carbone Cancer Center.
23
23UC San Diego Moores Cancer Center.
24
24Pancreatic Cancer Action Network.
25
25Memorial Sloan Kettering Cancer Center.
26
26University of Alabama at Birmingham Comprehensive Cancer Center.
27
27Fred & Pamela Buffett Cancer Center.
28
28The University of Texas MD Anderson Cancer Center; and.
29
29National Comprehensive Cancer Network.

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

PMID:
30865919
DOI:
10.6004/jnccn.2019.0014

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center